I don't know but I'm guessing at least a year after recruitment begins for a data update. Once the trial is in Clinicaltrials.gov with recruitment timelines, we will have a better picture.
What we need to do is manage our expectations and go for the long haul. This stock is a winner IMO. Do not expect it to take off in the next 6 months or even a year. But as data from Perkin Elmer, Heat Biologics and Merck starts to come in, if it's good, the pps should climb nicely to where it deserves to be.